Swissmedic
The article highlights the key points related to the regulatory requirements for combination studies intended to be carried out in Switzerland.
Australia
The article highlights the key points related to the regulatory status of boundary products in Australia.
CHMP
The article highlights the key points associated with the regulatory framework for specific categories of medicinal products.
EU
The article provides an overview of the approach to be applied when calculating regulatory fees associated with registration and authorization for medicines intended to be marketed and used in Ireland.
Gartner® Market Guide for Life Science Regulatory Information Management Solutions
Download NowGartner® Market Guide for Regulatory Intelligence Solutions
Download Now
